The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer

World Journal of Urology

Volumn 34, Issue 2, 2016, Pages 181-187

  Horn, T ^a,c   Laus, J ^a   Seitz, A K ^a   Maurer, T ^a   Schmid, S C ^a   Wolf, P ^b   Haller, B ^b   Winkler, M ^b   Retz, M ^a   Nawroth, R ^a   Gschwend, J E ^a   Kubler H R ^a   Slotta Huspenina, J ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bladder cancer; Lymphocyte; Prognosis; Regulatory T cell

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; AGED; BLADDER TUMOR; CANCER STAGING; CD8+ T LYMPHOCYTE; EPIDEMIOLOGY; FEMALE; FOLLOW UP; GERMANY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; TRANSITIONAL CELL CARCINOMA; TRENDS; TUMOR ASSOCIATED LEUKOCYTE; VERY ELDERLY;

ADAPTIVE IMMUNITY; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84956598126     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1615-3     Document Type: Article

References (21)

1. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331:1565–1570
2. Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964
3. Mlecnik B, Tosolini M, Kirilovsky A et al (2011) Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol 29:610–618
4. Sharma P, Shen Y, Wen S et al (2007) CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci USA 104:3967–3972
5. Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538–18543
6. Zhang L, Conejo-Garcia JR, Katsaros D et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203–213
7. Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593
8. Salama P, Phillips M, Grieu F et al (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192
9. Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949
10. Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423–5434
11. Winerdal ME, Marits P, Winerdal M et al (2011) FOXP3 and survival in urinary bladder cancer. BJU Int 108(10):1672–1678
12. Therneau T, Grambsch P (2000) Modeling survival data: extending the Cox model. Springer, New York
13. Hothorn T, Zeileis A (2008) Generalized maximally selected statistics Bias in random forest variable importance measures: illustrations, sources and a solution. Biometrics 64(4):1263–1269
14. Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343–346
15. Horn T, Grab J, Schusdziarra J et al (2013) Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches. Int J Cancer 133:2145–2156
16. Otto W, Denzinger S, Wieland WF, Hartmann A (2012) First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival. World J Urol 30:875–877
17. + regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 13(3):902–911
18. Choi W, Porten S, Kim S et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25(2):156–165
19. Powles T, Eder JP, Fine GD et al (2014) MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 515:558–562
20. Xylinas E, Robinson BD, Kluth LA et al (2014) Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. Eur J Surg Oncol 40:121–127
21. Bellmunt J, Mullane SA, Werner L, Fay AP, Callea M, Leow JJ, Taplin ME, Choueiri TK, Hodi FS, Freeman GJ, Signoretti S (2015) Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma. Ann Oncol 26(4):812–817. doi:10.1093/annonc/mdv009